Cinclus Pharma Holding AB
🇸🇪Sweden
Investigate Linaprazan Glurate/Linaprazan in Healthy Subjects
Phase 1
Completed
- Conditions
- GERD
- Interventions
- Drug: linaprazan glurate 25 mg QDDrug: linaprazan glurate 50 mg QDDrug: linaprazan glurate 75 mg QDDrug: linaprazan glurate 25 mg BIDDrug: linaprazan glurate 50 mg BIDDrug: linaprazan glurate 75 mg BID
- First Posted Date
- 2023-02-24
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Cinclus Pharma Holding AB
- Target Recruit Count
- 75
- Registration Number
- NCT05742984
- Locations
- 🇸🇮
CRS d.o.o,Ukmarjeva ulica 6, Ljubljana, Slovenia
Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam
Phase 1
Completed
- Conditions
- TolerabilitySafety IssuesPharmacokineticsDrug Interaction
- Interventions
- Drug: Drug drug interaction (DDI) - Midazolam (Part 2)
- First Posted Date
- 2022-12-01
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Cinclus Pharma Holding AB
- Target Recruit Count
- 35
- Registration Number
- NCT05633147
- Locations
- 🇸🇪
CTC Clinical Trials Consultants AB, Uppsala, Sweden
Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation
Phase 1
Completed
- Conditions
- SafetyPharmacokineticsBioavailability
- Interventions
- First Posted Date
- 2022-11-25
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Cinclus Pharma Holding AB
- Target Recruit Count
- 67
- Registration Number
- NCT05627518
- Locations
- 🇸🇮
CRS d.o.o., Ljubljana, Ukmarjeva Ulica 6, Slovenia
© Copyright 2025. All Rights Reserved by MedPath